Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients

NCT05377034 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Hepatocellular Carcinoma

Interventions

COMBINATION_PRODUCT: SIRT-Y90 with Atezolizumab + Bevacizumab
COMBINATION_PRODUCT: SIRT-Y90 with Placebo (IV)

Sponsor

National Cancer Centre, Singapore

Collaborators

[object Object]
[object Object]
[object Object]